Literature DB >> 29957282

Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.

Wei-Sheng Chung1, Cheng-Li Lin2.   

Abstract

BACKGROUND: The clinical phenotypes of chronic obstructive pulmonary disease (COPD) are related to various outcomes. We investigated the risk of acute respiratory events in patients with bronchiectasis-COPD overlap syndrome (BCOS) in Taiwan.
METHODS: We included 3955 patients who received diagnoses of COPD and bronchiectasis from 2000 to 2007 from the Taiwan Longitudinal Health Insurance Database in the BCOS cohort. In the comparison cohort, we included patients with COPD but without bronchiectasis at a ratio of 4:1, frequency matched by age, sex, and index year with each patient with BCOS. We followed both cohorts for 5 years to investigate the incidence and risk of acute respiratory events in the BCOS cohort relative to the comparison cohort, the incidence rate ratios (IRRs) and corresponding 95% confidence intervals (CIs) were determined using Poisson regression models.
RESULTS: The BCOS cohort experienced more episodes of acute respiratory events than did the comparison cohort (16.4 vs 5.52 per 100 person-y). After adjustment for potential covariates, the BCOS cohort had a 2.20-fold higher risk of pneumonia (adjusted IRR = 2.20, 95% CI = 2.06-2.34), a 3.88-fold higher risk of acute exacerbation (adjusted IRR = 3.88,95% CI = 3.64-4.13), a 1.74-fold higher risk of acute respiratory failure (adjusted IRR = 1.74,95% CI = 1.47-2.06), and a 1.99-fold higher risk of cardiopulmonary arrest (adjusted IRR = 1.99,95% CI = 1.81-2.20) than did the comparison cohort.
CONCLUSION: The patients with BCOS had a higher risk of acute respiratory events than did COPD patients without bronchiectasis.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Bronchiectasis- COPD overlap syndrome (BCOS); Chronic obstructive pulmonary disease (COPD); Exacerbation; Pneumonia

Mesh:

Year:  2018        PMID: 29957282     DOI: 10.1016/j.rmed.2018.05.008

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Journal Club-- COPD Exacerbations and Gastroesophageal Reflux Disease: Why Proton Pump Inhibitor Therapy is Not Enough.

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

2.  Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides.

Authors:  Benyong Xu; Yanhua Mao; Xiaoyu Wan; Jianhui Chen; Meiping Ye; Mengling Zhan; Liyun Xu; Lan Zhao; Bing Li; Zhemin Zhang; Yang Liu; Haiqing Chu
Journal:  Can Respir J       Date:  2019-03-10       Impact factor: 2.409

3.  Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study.

Authors:  Jun-Jun Yeh; Yu-Cih Yang; Chung Y Hsu; Chia-Hung Kao
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810

4.  [Bronchial dilatations in patients with chronic obstructive pulmonary disease in a Tunisian center: effect on disease progression and prognosis].

Authors:  Ahmed Ben Saad; Asma Migaou; Saousen Cheikh Mhamed; Nesrine Fahem; Naceur Rouatbi; Samah Joobeur
Journal:  Pan Afr Med J       Date:  2020-10-29

5.  [Bronchiectasis associated with chronic obstructive pulmonary disease: clinical and evolutionary profile].

Authors:  Chaima Habouria; Imen Bachouch; Nidhal Belloumi; Chahida Harizi; Fatma Chermiti; Soraya Fenniche
Journal:  Pan Afr Med J       Date:  2020-11-18

6.  Chronic Obstructive Pulmonary Disease as a Phenotype of Bronchiectasis for Long-Term Clinical Presentation and Treatment.

Authors:  Chih-Yi Hsu; Yan-Yuen Poon; Yu-Wei Chen; Meng-Heng Hsieh; Horng-Chyuan Lin; Wen-Feng Fang
Journal:  Medicina (Kaunas)       Date:  2021-06-05       Impact factor: 2.430

7.  Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.

Authors:  Diego Jose Maselli; Andrew Yen; Wei Wang; Yuka Okajima; Wojciech R Dolliver; Christina Mercugliano; Antonio Anzueto; Marcos I Restrepo; Timothy R Aksamit; Ashwin Basavaraj; Stefano Aliberti; Kendra A Young; Gregory L Kinney; J Michael Wells; Raúl San José Estépar; David A Lynch; Alejandro A Diaz
Journal:  Radiology       Date:  2021-06-22       Impact factor: 29.146

8.  Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.

Authors:  Min He; Min Zhu; Chengdi Wang; Zuohong Wu; Xiaofeng Xiong; Hongxia Wu; Deyun Cheng; Yulin Ji
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.